Clinical trial
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
NCT04245150 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 21, 2019
- Completion date
- July 30, 2024
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dcis, invasive breast cancer